Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 01-2019 | 01-2018 | 01-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,697 | -29,127 | 6,675 | -14,176 | -34,393 |
| Depreciation Amortization | 2,003 | 1,638 | 1,510 | 320 | 78 |
| Accounts receivable | 212 | 5,439 | -2,943 | N/A | 658 |
| Accounts payable and accrued liabilities | 1,642 | -1,306 | 123 | 4,392 | 1,088 |
| Other Working Capital | 5,000 | 2,009 | -51,772 | -10,541 | 42,588 |
| Other Operating Activity | -4,271 | 590 | 10,858 | 889 | 6,225 |
| Operating Cash Flow | $-48,111 | $-20,757 | $-35,549 | $-19,116 | $16,243 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -421 | -205 | -158 | -469 | -108 |
| Net Acquisitions | N/A | N/A | N/A | -6,214 | N/A |
| Purchase Sale Intangibles | N/A | -136 | -8 | -155 | N/A |
| Other Investing Activity | 0 | -136 | -257 | -139 | 1 |
| Investing Cash Flow | $-421 | $-341 | $-415 | $-6,822 | $-107 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 50,599 | 50,417 | 46,103 | 19,941 | 379 |
| Other Financing Activity | -48 | -912 | -1,742 | -1,845 | 174 |
| Financing Cash Flow | $50,551 | $49,505 | $44,361 | $18,096 | $553 |
| Exchange Rate Effect | 556 | 190 | 567 | -2,517 | -958 |
| Beginning Cash Position | 63,842 | 35,245 | 26,669 | 36,520 | 21,813 |
| End Cash Position | 66,417 | 63,842 | 35,633 | 26,161 | 37,544 |
| Net Cash Flow | $2,575 | $28,597 | $8,963 | $-10,359 | $15,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,111 | -20,757 | -35,549 | -19,116 | 16,243 |
| Capital Expenditure | -421 | -205 | -158 | -469 | -108 |
| Free Cash Flow | -48,532 | -20,962 | -35,707 | -19,585 | 16,135 |